Martin Currie LTD Sanofi Transaction History

Martin Currie LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $7,173 - $7,796	-145 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $1,759 - $2,152	41 Added 39.42%	145 $7,000
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $950 - $1,291	25 Added 31.65%	104 $5,000
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $3,598 - $3,942	-89 Reduced 52.98%	79 $3,000
Q1 2019 May 15, 2019	SELL	$40.83 - $45.43 $1,306 - $1,453	-32 Reduced 16.0%	168 $7,000
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $3,480 - $3,901	87 Added 76.99%	200 $9,000
Q1 2018 May 15, 2018	BUY	$38.98 - $45.76 $1,948 - $2,288	50 Added 79.37%	113 $5,000
Q4 2017 Feb 14, 2018	BUY	$42.86 - $50.61 $2,700 - $3,188	63	63 $3,000

808

253M

2.6M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $133B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

Stay updated on Martin Currie LTD with notifications on news.